Nicotine Transdermal System Patch
NDC Package 84720-122-14
Package Information
Nicotine Transdermal System patches is if you are under 18 years of age, ask a doctor before usebefore using this product, read the enclosed self-help guide for complete directions and other information.begin using the patch on your quit dayif you smoke more than 10 cigarettes per day,use the following schedule below: Weeks 1 thru 4Weeks 5 and 6 Weeks 7 and 8 Step 1Step 2Step 3 use one 21 mg patch/day use one 14 mg patch/day use one 7 mg patch/dayif you smoke 10 or less cigarettes per day, start with Step 2 for 6 weeks, then Step 3 for 2 weeks apply one new patch every 24 hours on skin that is dry, clean, and hairless remove backing from patch and immediately press onto skin. This formulation utilizes a patch delivery system. Marketed by Quitine Llc, this product is identified by NDC 84720-122 and is authorized under FDA application ANDA074612.
Identification & Billing
- RxCUI: 198029 - nicotine 14 MG/Day 24HR Transdermal System
- RxCUI: 198029 - 24 HR nicotine 0.583 MG/HR Transdermal System
- RxCUI: 198029 - nicotine 0.583 MG/HR 24HR Transdermal Patch
- RxCUI: 198029 - nicotine 14 MG per 24HR 1 Day Transdermal Patch
- RxCUI: 198030 - nicotine 21 MG/Day 24HR Transdermal System
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 84720 - Quitine Llc
- 84720-122 - Nicotine Transdermal System
- 84720-122-14 - 14 PATCH in 1 CARTON / 1 h in 1 PATCH
- 84720-122 - Nicotine Transdermal System
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (84720-122). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84720-122-14 identifies a specific commercial package of 14 patch in 1 carton / 1 h in 1 patch of Nicotine Transdermal System, a human over the counter drug labeled by Quitine Llc. This patch is formulated for transdermal use and contains nicotine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Quitine Llc on March 26, 2026. The current certification is valid through December 31, 2027.
How is this Quitine Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84720012214. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.